Ventas, Inc.
Long book
$80.0M
Q1 2026
Positions
1
Top-10 weight
100%
concentration
Last quarter
+25.7%
SPY +14.8%
Turnover
0%
of book per quarter
Strategy in plain words
auto-generated from filingsVentas, Inc. is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $80.0M US long book across 1 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: ARDENT HEALTH INC.
Over the last 4 quarters its long book ran on average 9.8pp per quarter behind the S&P 500, beating the index in 2 of 4 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2024
-19.5%
Q3 2025
-33.4%
Q4 2025
-3.1%
Q1 2026
+25.7%
Sector allocation
Healthcare 100%
Long book by quarter
What does Ventas, Inc. own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| ARDT ARDENT HEALTH INC | Healthcare | 9.3M | $80.0M | 100.0% | Held |